by Garth Sundem | Nov 29, 2018 | Featured, Latest News, Patient Care, Research
Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML). Of 33 patients given combination venetoclax and...
by Garth Sundem | Nov 12, 2018 | Featured, Latest News, Research
Think of energy metabolism like a party popper: Ripping something apart releases a bang. Most of your cells rip apart sugar to release the “bang” of energy. A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that cancer stem...
by Garth Sundem | Sep 28, 2018 | Featured, Latest News, Research
Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption – where there is consumption, there is cancer. But...
by Garth Sundem | Sep 12, 2018 | Featured, Latest News, Research
Your body’s blood cells are manufactured by hematopoietic stem cells in bone marrow. But just as regular, mature cells can become cancerous, so too can stem cells. When hematopoietic stem cells mutate in specific ways, the result can be damaged stem cells that create...
by Taylor Abarca | Dec 7, 2017 | C3 Magazine, Patient Care
“I I have had a good life,” They’re the words of someone who believes they are nearing the end. This is exactly what Richard Berger, husband, father, grandfather and 27-year Marine Corps veteran, said to his family as they sat in a hospital room on the...
